Hanwha Investment & Securities' "Korea Leading Stocks VA Lab" Surpasses 100 Billion Won in Cumulative Sales

On October 20, Hanwha Investment & Securities announced that the cumulative sales of its "Korea Leading Stocks VA Lab" have surpassed 100 billion won.

The Korea Leading Stocks VA Lab constructs a portfolio centered on leading domestic companies such as Samsung Electronics, Hyundai Motor Company, and NAVER, taking into account market capitalization and liquidity, and operates it using a Value Averaging (VA) strategy. The Value Averaging strategy utilizes the maximum drawdown (MDD) from the previous peak, aiming to reduce the average purchase price through incremental buying, buying at lows and selling at highs, and flexibly adjusting the proportion of stocks in the portfolio.

Since its launch, the Korea Leading Stocks VA Lab has expanded its investment scope across various industries and consistently delivered strong performance, resulting in cumulative sales surpassing 100 billion won.

Hanwha Investment & Securities offers a variety of VA Lab services, including the "US Stocks VA Lab" and "China Stocks VA Lab," with total cumulative sales exceeding 250 billion won.

Ryu Eunsik, Executive Director of Product Strategy at Hanwha Investment & Securities, stated, "The Korea Leading Stocks VA Lab is a rational investment tool that can respond proactively to changes in the domestic stock market," adding, "We will continue to introduce a wide range of products to meet our customers' needs."

This content was produced with the assistance of AI translation services.